OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synaptic dysfunction in Parkinson's disease
Vincenza Bagetta, Veronica Ghiglieri, Carmelo Sgobio, et al.
Biochemical Society Transactions (2010) Vol. 38, Iss. 2, pp. 493-497
Closed Access | Times Cited: 153
Vincenza Bagetta, Veronica Ghiglieri, Carmelo Sgobio, et al.
Biochemical Society Transactions (2010) Vol. 38, Iss. 2, pp. 493-497
Closed Access | Times Cited: 153
Showing 26-50 of 153 citing articles:
Targeting Human Central Nervous System Protein Kinases: An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease Progression in Alzheimer’s Disease Mouse Models
Saktimayee M. Roy, Valerie Grum‐Tokars, James P. Schavocky, et al.
ACS Chemical Neuroscience (2015) Vol. 6, Iss. 4, pp. 666-680
Open Access | Times Cited: 85
Saktimayee M. Roy, Valerie Grum‐Tokars, James P. Schavocky, et al.
ACS Chemical Neuroscience (2015) Vol. 6, Iss. 4, pp. 666-680
Open Access | Times Cited: 85
NMDA receptors
Eduardo E. Benarroch
Neurology (2011) Vol. 76, Iss. 20, pp. 1750-1757
Closed Access | Times Cited: 80
Eduardo E. Benarroch
Neurology (2011) Vol. 76, Iss. 20, pp. 1750-1757
Closed Access | Times Cited: 80
Loss and remodeling of striatal dendritic spines in Parkinson’s disease: from homeostasis to maladaptive plasticity?
Rosa M. Villalba, Yoland Smith
Journal of Neural Transmission (2017) Vol. 125, Iss. 3, pp. 431-447
Open Access | Times Cited: 80
Rosa M. Villalba, Yoland Smith
Journal of Neural Transmission (2017) Vol. 125, Iss. 3, pp. 431-447
Open Access | Times Cited: 80
Therapeutic Utility of Phosphodiesterase Type I Inhibitors in Neurological Conditions
Alexandre E. Medina
Frontiers in Neuroscience (2011) Vol. 5
Open Access | Times Cited: 79
Alexandre E. Medina
Frontiers in Neuroscience (2011) Vol. 5
Open Access | Times Cited: 79
Glycine Transport Inhibitors in the Treatment of Schizophrenia
Daniel C. Javitt
Handbook of experimental pharmacology (2012), pp. 367-399
Closed Access | Times Cited: 78
Daniel C. Javitt
Handbook of experimental pharmacology (2012), pp. 367-399
Closed Access | Times Cited: 78
Deep Brain Stimulation: Are Astrocytes a Key Driver Behind the Scene?
Albert J. Fenoy, Laurent Goetz, Stéphan Chabardès, et al.
CNS Neuroscience & Therapeutics (2014) Vol. 20, Iss. 3, pp. 191-201
Open Access | Times Cited: 77
Albert J. Fenoy, Laurent Goetz, Stéphan Chabardès, et al.
CNS Neuroscience & Therapeutics (2014) Vol. 20, Iss. 3, pp. 191-201
Open Access | Times Cited: 77
Cortical Plasticity Induction by Pairing Subthalamic Nucleus Deep-Brain Stimulation and Primary Motor Cortical Transcranial Magnetic Stimulation in Parkinson's Disease
Kaviraja Udupa, Nina Bahl, Zhen Ni, et al.
Journal of Neuroscience (2016) Vol. 36, Iss. 2, pp. 396-404
Open Access | Times Cited: 71
Kaviraja Udupa, Nina Bahl, Zhen Ni, et al.
Journal of Neuroscience (2016) Vol. 36, Iss. 2, pp. 396-404
Open Access | Times Cited: 71
Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD
Alexander Starr, Rita Sattler
Brain Research (2018) Vol. 1693, pp. 98-108
Open Access | Times Cited: 70
Alexander Starr, Rita Sattler
Brain Research (2018) Vol. 1693, pp. 98-108
Open Access | Times Cited: 70
Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy
Subrata Pramanik, Yanuar Alan Sulistio, Klaus Heese
Molecular Neurobiology (2016) Vol. 54, Iss. 9, pp. 7401-7459
Closed Access | Times Cited: 69
Subrata Pramanik, Yanuar Alan Sulistio, Klaus Heese
Molecular Neurobiology (2016) Vol. 54, Iss. 9, pp. 7401-7459
Closed Access | Times Cited: 69
Autophagy in synaptic development, function, and pathology
Dan-Na Shen, Lihui Zhang, Er-Qing Wei, et al.
Neuroscience Bulletin (2015) Vol. 31, Iss. 4, pp. 416-426
Open Access | Times Cited: 68
Dan-Na Shen, Lihui Zhang, Er-Qing Wei, et al.
Neuroscience Bulletin (2015) Vol. 31, Iss. 4, pp. 416-426
Open Access | Times Cited: 68
Linking pathways in the developing and aging brain with neurodegeneration
Gábor G. Kovács, Homa Adle‐Biassette, Ivan Milenković, et al.
Neuroscience (2014) Vol. 269, pp. 152-172
Closed Access | Times Cited: 67
Gábor G. Kovács, Homa Adle‐Biassette, Ivan Milenković, et al.
Neuroscience (2014) Vol. 269, pp. 152-172
Closed Access | Times Cited: 67
Building a Bridge Between NMDAR-Mediated Excitotoxicity and Mitochondrial Dysfunction in Chronic and Acute Diseases
Rodrigo G. Mira, Waldo Cerpa
Cellular and Molecular Neurobiology (2020) Vol. 41, Iss. 7, pp. 1413-1430
Closed Access | Times Cited: 57
Rodrigo G. Mira, Waldo Cerpa
Cellular and Molecular Neurobiology (2020) Vol. 41, Iss. 7, pp. 1413-1430
Closed Access | Times Cited: 57
Signaling Pathways Involved in the Neuroprotective Effect of Osthole: Evidence and Mechanisms
Lovedeep Singh, Rajbir Bhatti
Molecular Neurobiology (2023) Vol. 61, Iss. 2, pp. 1100-1118
Closed Access | Times Cited: 17
Lovedeep Singh, Rajbir Bhatti
Molecular Neurobiology (2023) Vol. 61, Iss. 2, pp. 1100-1118
Closed Access | Times Cited: 17
Motor Cortical Plasticity in Parkinson’s Disease
Kaviraja Udupa, Robert Chen
Frontiers in Neurology (2013) Vol. 4
Open Access | Times Cited: 71
Kaviraja Udupa, Robert Chen
Frontiers in Neurology (2013) Vol. 4
Open Access | Times Cited: 71
Role of Sirtuins and Calorie Restriction in Neuroprotection: Implications in Alzheimers and Parkinsons Diseases
Sarika Srivastava, Marcia C. Haigis
Current Pharmaceutical Design (2011) Vol. 17, Iss. 31, pp. 3418-3433
Closed Access | Times Cited: 68
Sarika Srivastava, Marcia C. Haigis
Current Pharmaceutical Design (2011) Vol. 17, Iss. 31, pp. 3418-3433
Closed Access | Times Cited: 68
The pathomechanisms underlying Parkinson's disease
K. A. Jellinger
Expert Review of Neurotherapeutics (2014) Vol. 14, Iss. 2, pp. 199-215
Closed Access | Times Cited: 66
K. A. Jellinger
Expert Review of Neurotherapeutics (2014) Vol. 14, Iss. 2, pp. 199-215
Closed Access | Times Cited: 66
Metabotropic Glutamate Receptors for Parkinson's Disease Therapy
F. Gasparini, Thérèse Di Paolo, Baltazar Gomez‐Mancilla
Parkinson s Disease (2013) Vol. 2013, pp. 1-11
Open Access | Times Cited: 62
F. Gasparini, Thérèse Di Paolo, Baltazar Gomez‐Mancilla
Parkinson s Disease (2013) Vol. 2013, pp. 1-11
Open Access | Times Cited: 62
Morphological changes of glutamatergic synapses in animal models of Parkinson’s disease
Rosa M. Villalba, Abraham Mathai, Yoland Smith
Frontiers in Neuroanatomy (2015) Vol. 9
Open Access | Times Cited: 62
Rosa M. Villalba, Abraham Mathai, Yoland Smith
Frontiers in Neuroanatomy (2015) Vol. 9
Open Access | Times Cited: 62
Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of H untington's disease
JG Doria, FR Silva, JM de Souza, et al.
British Journal of Pharmacology (2013) Vol. 169, Iss. 4, pp. 909-921
Open Access | Times Cited: 59
JG Doria, FR Silva, JM de Souza, et al.
British Journal of Pharmacology (2013) Vol. 169, Iss. 4, pp. 909-921
Open Access | Times Cited: 59
STEP 61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson’s disease
Pradeep Kurup, Jian Xu, Rita Alexandra Videira, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 4, pp. 1202-1207
Open Access | Times Cited: 58
Pradeep Kurup, Jian Xu, Rita Alexandra Videira, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 4, pp. 1202-1207
Open Access | Times Cited: 58
Closing the gap: long-term presynaptic plasticity in brain function and disease
Hannah R. Monday, Pablo E. Castillo
Current Opinion in Neurobiology (2017) Vol. 45, pp. 106-112
Open Access | Times Cited: 57
Hannah R. Monday, Pablo E. Castillo
Current Opinion in Neurobiology (2017) Vol. 45, pp. 106-112
Open Access | Times Cited: 57
Centrality of Early Synaptopathy in Parkinson’s Disease
Paola Imbriani, Tommaso Schirinzi, Maria Meringolo, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 48
Paola Imbriani, Tommaso Schirinzi, Maria Meringolo, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 48
Enhanced ATP release and CD73‐mediated adenosine formation sustain adenosine A2A receptor over‐activation in a rat model of Parkinson's disease
Marta Regina Santos do Carmo, Francisco Q. Gonçalves, Paula M. Canas, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 18, pp. 3666-3680
Open Access | Times Cited: 48
Marta Regina Santos do Carmo, Francisco Q. Gonçalves, Paula M. Canas, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 18, pp. 3666-3680
Open Access | Times Cited: 48
Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders
K. A. Jellinger
Journal of Neural Transmission (2019) Vol. 126, Iss. 8, pp. 933-995
Closed Access | Times Cited: 43
K. A. Jellinger
Journal of Neural Transmission (2019) Vol. 126, Iss. 8, pp. 933-995
Closed Access | Times Cited: 43
D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson’s disease
Irene Sebastianutto, Elise Goyet, Laura Andreoli, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 3, pp. 1168-1184
Open Access | Times Cited: 40
Irene Sebastianutto, Elise Goyet, Laura Andreoli, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 3, pp. 1168-1184
Open Access | Times Cited: 40
